Rachel E. Carlson
0000-0002-6628-3344
Publication & Citation Trends
Most Cited Works
Publications
90 total
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients PDF
Cited by 39
OpenAlex
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance PDF
Cited by 162
OpenAlex
A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate–prednisone PDF
Cited by 96
OpenAlex
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study PDF
Cited by 134
OpenAlex
The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy
Cited by 115
OpenAlex
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer PDF
Cited by 35
OpenAlex
Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?
Cited by 75
OpenAlex
Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy PDF
Cited by 46
OpenAlex
Research Topics
Prostate Cancer Treatment and Research
(65)
Prostate Cancer Diagnosis and Treatment
(35)
Cancer, Lipids, and Metabolism
(25)
Estrogen and related hormone effects
(16)
Radiopharmaceutical Chemistry and Applications
(10)
Frequent Co-Authors
Affiliations
University of Vermont
Mayo Clinic
University of British Columbia
WinnMed
Unity Health System